Latest peptide industry news
FDA letters. Vendor shutdowns. Product drops. What people are saying next.
Empower Pharmacy
UNKNOWNLast checked
Not checked. Listed because of an FDA warning letter; we did not review the company’s site.
Latest item
Sept. 18, 2026: FDA dated a warning letter to Empower Clinic Services, LLC, doing business as Empower Pharmacy, citing compounded semaglutide and tirzepatide products and sterile-production findings.
Public enforcement record
FDA warning letter dated Sept. 18, 2026 (CDER), following a Nov. 3 to 14, 2025 inspection. FDA’s allegations; not a court finding. We found no further agency action.
Company response
None located.
Common questions about Empower Pharmacy
What happened to Empower Pharmacy?
Sept. 18, 2026: FDA dated a warning letter to Empower Clinic Services, LLC, doing business as Empower Pharmacy, citing compounded semaglutide and tirzepatide products and sterile-production findings.
Is Empower Pharmacy still operating?
We have not established Empower Pharmacy's current status. Last check: Not checked. Listed because of an FDA warning letter; we did not review the company’s site. The status stays unknown until we have a dated observation.
Why did Empower Pharmacy receive an FDA warning letter?
FDA says Empower compounded tirzepatide with niacinamide and semaglutide with cyanocobalamin that were essentially copies of commercially available drugs, that prescriber statements of a significant difference looked repeated verbatim across records, and that its sterile production had gaps in smoke studies, media fills and records. These are FDA’s allegations in a letter dated Sept. 18, 2026, not court findings.
Is Empower Pharmacy being shut down?
The letter is not a shutdown order. It gives the firm 15 working days to describe corrective actions and warns that failure to correct violations may lead to legal action, including seizure and injunction. We found no closure or further action.
Can adding a vitamin make a compounded semaglutide or tirzepatide legally different?
We state no general rule. In this letter, FDA treated tirzepatide with niacinamide and semaglutide with cyanocobalamin as essentially copies, and questioned significant-difference statements that repeated verbatim across records. FDA frames it as an individualized clinical judgment by the prescriber.
What does the letter mean for patients with prescriptions from Empower?
The letter is addressed to the company, and we saw no instruction to patients in it. Questions about a prescription belong with your prescriber or pharmacist. This is not medical advice.
Is Empower Pharmacy legit?
We do not rate companies or issue legit or not-legit verdicts. What we can document is the status and last check, the public enforcement record, any company response, and the linked sources. A listing here is not an endorsement, and an FDA warning letter is FDA's stated position, not a court finding.
Who is behind Empower Pharmacy?
Names on the public record: Empower Clinic Services, LLC. We list names only as they appear in the linked documents, and have not identified owners beyond them.
What does the FDA warning letter to Empower Pharmacy mean?
A warning letter states FDA's position that a firm is violating the law and asks for a written response, usually within 15 working days. It is not a court finding, and it does not by itself close a business. FDA's allegations about this firm are in the linked letter.
Timeline
Current storefront and channel observations
No observations recorded.
Documented enforcement records
Product additions and removals
No product changes recorded.
Statements and replies
No statements located.
Stories
Community chatter
None recorded.
Updates and corrections
None. Request a correction.
Built from public documents, dated website observations and company statements. Community discussion is labeled as such.